|March 2013||RegeneCure's Membrane Implant Shows 40% Accelerated Healing Time of Severe Bone Fractures in Pet Clinical Study|
Jerusalem, Israel, March 12, 2013 / B3C newswire / - RegeneCure announced today the successful results of a clinical study in pets using the company's regenerative membrane implant technology for the treatment of bone fractures. The study showed that the healing time was about 40 percent quicker than normally observed using current Standard of Care therapies. The product was also demonstrated to be safe in all of the study participants.
"The healing time for animals treated in the participating clinical study sites with injuries that normally take from five to twelve months was in many cases reduced to just eight weeks," said Dr. Michal Limor, VP Medical Affairs of RegeneCure.
Read more >>>
|07.3.2011||Yissum and Hadasit license regenerative polymeric membrane implants to REGENECURE|
Read more >>>
REGENECURE specializes in the development of biomaterials and bone tissue engineering focusing on the design, manufacture, and marketing of innovative products for the global orthopedic and dental surgery markets.
Our products provide guided bone regeneration for applications in trauma, spine, and reconstructive cranial and facial orthopedics. Our AMCA Bone Membrane offers user-friendly regenerative implants for minimally invasive procedures to help the body heal faster.
REGENECURE takes pleasure in introducing BoneCure® the first regenerative membrane implant developed for household pets: www.bonecure.co.il